Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Overview

Información sobre este estudio

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria - Patient:

  • Diagnosed with advanced NSCLC being treated with non-curative intent, and informed of advanced disease within the prior 8-12 weeks.
  • Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed >50% of the day).
  • The ability to read and respond to questions in English or Spanish.
  • Lives in a state where their institutions’ PC clinicians are licensed to practice.
  • Receiving primary cancer care at one of the participating sites.
  • Age > 18 years.

Inclusion Criteria - Caregiver:

  • Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week.
  • The ability to read and respond to questions in English or Spanish.
  • Age ≥ or 18 years.

Exclusion Criteria - Patient:

  • Already receiving PC or hospice services.
  • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.

Exclusion Criteria - Caregiver:

  • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Konstantinos Leventakos, M.D., Ph.D.

Cerrado para la inscripción

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publicaciones

Publications are currently not available
.
CLS-20425293

Mayo Clinic Footer